ALPS Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$585K Buy
71,906
+459
+0.6% +$3.94K ﹤0.01% 674
2025
Q4
$742K Buy
71,447
+32,465
+83% +$341K ﹤0.01% 646
2025
Q3
$345K Sell
38,982
-7,678
-16% -$54.7K ﹤0.01% 938
2025
Q2
$269K Buy
+46,660
New +$286K ﹤0.01% 958
2024
Q4
Sell
-58,695
Closed -$1.15M 1023
2024
Q3
$1.15M Sell
58,695
-708
-1% -$14.3K 0.01% 465
2024
Q2
$1.22M Buy
59,403
+5,703
+11% +$117K 0.01% 421
2024
Q1
$1.15M Buy
53,700
+3,221
+6% +$62.6K 0.01% 442
2023
Q4
$726K Sell
50,479
-4,270
-8% -$42K 0.01% 552
2023
Q3
$499K Buy
54,749
+4,441
+9% +$45.1K ﹤0.01% 598
2023
Q2
$532K Buy
50,308
+5,215
+12% +$61.7K ﹤0.01% 604
2023
Q1
$551K Sell
45,093
-1,180
-3% -$14.7K ﹤0.01% 580
2022
Q4
$574K Buy
46,273
+9,806
+27% +$143K 0.01% 565
2022
Q3
$498K Sell
36,467
-3,058
-8% -$47.2K ﹤0.01% 589
2022
Q2
$724K Buy
+39,525
New +$569K 0.01% 523
2020
Q4
Sell
-71,775
Closed -$2.2M 864
2020
Q3
$2.2M Sell
71,775
-2,612
-4% -$57.7K 0.03% 226
2020
Q2
$1.21M Sell
74,387
-8,003
-10% -$115K 0.02% 283
2020
Q1
$820K Sell
82,390
-9,601
-10% -$110K 0.01% 314
2019
Q4
$1.26M Buy
91,991
+1,879
+2% +$27.8K 0.01% 280
2019
Q3
$1.37M Buy
90,112
+10,184
+13% +$181K 0.01% 255
2019
Q2
$1.57M Sell
79,928
-11,945
-13% -$198K 0.01% 259
2019
Q1
$1.52M Buy
91,873
+3,974
+5% +$61.2K 0.01% 259
2018
Q4
$1.23M Buy
87,899
+20,698
+31% +$274K 0.01% 262
2018
Q3
$1.18M Buy
67,201
+18,801
+39% +$360K 0.01% 345
2018
Q2
$881K Buy
48,400
+7,874
+19% +$133K 0.01% 360
2018
Q1
$760K Buy
40,526
+7,043
+21% +$137K 0.01% 366
2017
Q4
$512K Buy
+33,483
New +$493K ﹤0.01% 532

Other funds holding KURA